icon-folder.gif   Conference Reports for NATAP  
  The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
Treatment with Glecaprevir/Pibrentasvir (G/P)-based regimens of patients with difficult to treat HCV infection. A compassionate use study.
  Reported by Jules Levin
AASLD - American Association for the Study of Liver Diseases (AASLD) Congress, October 20-24, 2017, Washington, DC, USA
Victor de Ledinghen, Anne Varaut, Jose Ursic-Bedoya, Jean-Baptiste Hiriart, Giovanna Scoazec, Wassil Merrouche, Georges Philippe Pageaux, Christophe Hezode Bordeaux - Creteil - Montpellier (France)